Developers of Cardiovascular Drug-Eluting Stents
Company
Stent
Drug
Status
Abbott Vascular Devices
ZoMaxx
Zotarolimus
In clinicals; ZOMAXX II trial approved 6/05
Avantec Vascular (Goodman)
Duraflex
Pimecrolimus
In development
Biosensors International
BioMatrix
Biolimus A9
In trials; Expects CE Mark in 2006
Boston Scientific
Taxus Express2
Paclitaxel
CE Mark 1/03; FDA approval 3/04
Boston Scientific
Taxus Liberté
Paclitaxel
CE Mark 9/05 (launched 1/05); FDA approval expected mid-2006
Conor Medsystems
CoStar
Paclitaxel
CE Marked 2/06
Conor Medsystems
(Next-generation CoStar)
Pimecrolimus
Pimecrolimus licensed from Novartis in [...]
bookmark to
